Published in Crit Care on May 14, 2010
Efficacy and Safety of Panax notoginseng Saponin Therapy for Acute Intracerebral Hemorrhage, Meta-Analysis, and Mini Review of Potential Mechanisms of Action. Front Neurol (2015) 0.82
Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty. Vasc Health Risk Manag (2014) 0.79
Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 16.17
A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med (1998) 7.08
A prospective study of venous thromboembolism after major trauma. N Engl J Med (1994) 4.87
A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med (1996) 2.65
Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin: an assessment of safety and pharmacodynamics: the DIRECT study. Arch Intern Med (2008) 1.28
Prospective evaluation of the safety of enoxaparin prophylaxis for venous thromboembolism in patients with intracranial hemorrhagic injuries. Arch Surg (2002) 1.23
New antithrombotic drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 1.21
Silent deep vein thrombosis in immobilized multiple trauma patients. Am J Surg (1989) 1.11
Prophylactic anticoagulation to prevent venous thromboembolism in traumatic intracranial hemorrhage: a decision analysis. Crit Care (2010) 0.86
Acute thrombosis of a vena cava filter with a clot above the filter. Successful treatment with low-dose urokinase. Chest (1994) 0.84
Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department. Clin Infect Dis (2011) 3.78
Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol (2003) 3.46
Epidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: a multicenter cohort study. J Infect (2010) 1.83
Using the number needed to treat to assess appropriate antimicrobial therapy as a determinant of outcome in severe sepsis and septic shock. Crit Care Med (2014) 1.61
Readmission following hospitalization for pneumonia: the impact of pneumonia type and its implication for hospitals. Clin Infect Dis (2013) 1.60
Secular trends of hospitalization with vancomycin-resistant enterococcus infection in the United States, 2000-2006. Infect Control Hosp Epidemiol (2009) 1.58
Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia. Arch Intern Med (2008) 1.58
Growth in dementia-associated hospitalizations among the oldest old in the United States: implications for ethical health services planning. Arch Intern Med (2011) 1.46
Clostridium difficile-related hospitalizations among US adults, 2006. Emerg Infect Dis (2009) 1.39
Hospital resource utilization and costs of inappropriate treatment of candidemia. Pharmacotherapy (2010) 1.25
Alcohol-use disorders in the critically ill patient. Chest (2010) 1.07
Assessment of reporting bias for Clostridium difficile hospitalizations, United States. Emerg Infect Dis (2008) 1.05
Cost-effectiveness analysis of a silver-coated endotracheal tube to reduce the incidence of ventilator-associated pneumonia. Infect Control Hosp Epidemiol (2009) 0.99
Anemia, costs and mortality in chronic obstructive pulmonary disease. Cost Eff Resour Alloc (2006) 0.88
Anemia in chronic obstructive pulmonary disease: epidemiology and economic implications. Curr Med Res Opin (2008) 0.86
Predictors of hospital mortality among septic ICU patients with Acinetobacter spp. bacteremia: a cohort study. BMC Infect Dis (2014) 0.86
Attributable burden of hospital-onset Clostridium difficile infection: a propensity score matching study. Infect Control Hosp Epidemiol (2013) 0.85
Hospital days, hospitalization costs, and inpatient mortality among patients with mucormycosis: a retrospective analysis of US hospital discharge data. BMC Infect Dis (2014) 0.83
Outcomes and charges of elderly patients with acute myeloid leukemia. Am J Hematol (2006) 0.80
Outcomes of patients with healthcare-associated pneumonia: worse disease or sicker patients? Infect Control Hosp Epidemiol (2014) 0.79
Outcomes of patients with alcohol use disorders experiencing healthcare-associated infections. Alcohol Clin Exp Res (2011) 0.79
Severe acute hypertension among inpatients admitted from the emergency department. J Hosp Med (2011) 0.77
Azithromycin and survival in Streptococcus pneumoniae pneumonia: a retrospective study. BMJ Open (2013) 0.77
Diagnostics and epidemiology in ventilator-associated pneumonia. Ther Adv Respir Dis (2011) 0.77
The impact of anemia on quality of life and healthcare resource utilization in patients with HIV/AIDS receiving antiretroviral therapy. Curr Med Res Opin (2007) 0.77
Effectiveness versus convenience: patient preferences for an erythropoietic agent to treat cancer-related anemia. Curr Med Res Opin (2007) 0.76
Bacteremia increases the risk of death among patients with soft-tissue infections. Surg Infect (Larchmt) (2010) 0.76
Risk-benefit decision making in traumatic brain injury: Ratios, realities, results. J Emerg Trauma Shock (2012) 0.75
Prolonged mechanical ventilation: pushing the limits of magic in medicine? Crit Care Med (2009) 0.75
Customer satisfaction: coming to an intensive care unit near you! Crit Care Med (2012) 0.75
Case mix as the determinant of outcomes: the devil is in the details. Crit Care Med (2008) 0.75
The swan song of the pulmonary artery catheter. Crit Care Med (2013) 0.75
Endometriosis and ovarian cancer. Lancet Oncol (2012) 0.75
Ventilator-associated pneumonia: we cannot wish it away*. Crit Care Med (2014) 0.75
What conclusions should be drawn between critical care physician management and patient mortality in the intensive care unit? Ann Intern Med (2008) 0.75
Population health issue in critical care: expanding our focus beyond the intensive care unit. Crit Care Med (2012) 0.75
Bayesian thinking: a safer tool for reassurance. Arch Intern Med (2011) 0.75
Translational highway: it helps to have a map. Crit Care Med (2007) 0.75
Nature (and the ICU) abhors a VACuum. Chest (2012) 0.75
Admitting What We Do Not Know About Pneumonia Readmissions. Chest (2015) 0.75
Augmented renal clearance: an augmented definition of appropriate antibiotic therapy?*. Crit Care Med (2014) 0.75
Surviving sepsis: a time for "don't just do something, stand there" philosophy? Crit Care Med (2012) 0.75
Growth in the incidence of hospitalizations with resistant infections in elderly people in the United States: 2000 to 2006. J Am Geriatr Soc (2008) 0.75
Role for risk-scoring tools in identifying resistant pathogens in pneumonia: reassessing the value of healthcare-associated pneumonia as a concept. Curr Opin Pulm Med (2015) 0.75